Mental Health Series for Perinatal Prescribers. Pharmacotherapy for depression and anxiety
|
|
- Elijah Shields
- 5 years ago
- Views:
Transcription
1 Mental Health Series for Perinatal Prescribers Pharmacotherapy for depression and anxiety
2 Non-medication Treatments Psychosocial support Prenatal education, Doula support, La Leche League, Mom s groups, internet groups, meditation groups Optimize physical health Exercise, Nutrition, Sleep Psychotherapy Bright light therapy
3 FDA pregnancy categories (1979) A B C D X Adequate and well-controlled (AWC) studies in pregnant women: no evidence of risk 1-3 rd trimesters Animal studies no risk ; no AWC studies in pregnant women,or Animal studies- risk; AWC studies in pregnant women, no evidence of risk Animal studies- risk; no AWC studies in humans, AND benefits may be acceptable despite risks, OR No Animal studies or AWC studies in humans. Evidence of human fetal risk, BUT benefits may be acceptable despite risks (ie: life-threatening situation, serious disease for which safer drugs ineffective). Animal & human fetal abnormalities AND the risk of the use of the drug in a pregnant woman clearly outweighs any possible benefit (ie:safer drugs or other therapies are available). 28 July 2010 Prescribing Risks in Women Veterans of Childbearing Age 3
4 FDA new Pregnancy and Lactation Labeling Rule (June 30, 2015) Summary of pertinent studies that bear upon perinatal use of individual medications Summary of the risks Discussion of the data
5 There is no NO-RISK option Risk-benefit decision making process Risks of untreated mental illness to mother & offspring Risks known about psychotropic Ilness Meds
6 How to make sense of the data?
7 Statistics 101 Odds Ratio (OR) OR = 1 OR < 1 OR > 1 to no difference in risk between the two groups. outcome is less likely to occur in the exposed relative to unexposed group outcome is more likely to occur in the exposed relative unexposed group Confidence interval (CI) If it includes 1, the result is not significant
8 Absolute Risk Absolute risk = Base population risk * Relative risk Example: Cardiac malformations Paxil was associated with a **1.5-fold** increased risk Base population risk is 1 per 100 Absolute risk = 1/100 x 1.5 = 1.5/100 New data suggests OR of 1.06 ( ) Absolute risk of 1.06/100 Wurst et al (2009) Birth Defects Research; Huybrechts et al (2014) NEJM
9 Confounding X and Y may seem to be associated, until Z is controlled for X Y Common unmeasured variables (residual confounding) Medical comorbidity (prior preterm birth, pre-eclampsia, gestational diabetes, prenatal care), Other medications Psychiatric severity &comorbidity Poverty Trauma Tobacco, drug & alcohol use Nutrition Paternal factors Epi/genetic factors
10 Confounding by indication Depression comparison group Propensity score probability of a patient being in the antidepressant exposure group given a set of observed covariates balanced propensity score across the medication and comparison groups allows estimate of the effect of medication exposure by accounting for the covariates that predict having the exposure
11 Confounding by indication Maternal depression Medical comorbidity Medications Psychiatric severity &comorbidity Poverty Trauma Tobacco, drug & alcohol use Nutrition Paternal factors Epi/genetic factors Child outcomes
12 Domains of reproductive toxicity 1. Spontaneous Abortion 2. Birth defects 3. Persistent Hypertension of the Newborn (PPHN) 4. Timing of delivery, Birth weight 5. Neonatal complications 6. Lactation 7. Neurobehavioral disorders Ilness Meds
13 1. Spontaneous Abortion Smaller studies OR 1.6 ( ) Meta-analysis of moderate and low quality studies OR 1.47 ( ) (no depression control group) Larger studies with more robust statistical analyses RR 1.14 ( ) Adjustment for registry-based depression diagnosis RR 1.0 ( ) Kjaersgaard et al (2103) Plos One; Ross et al (2013) JAMA Psych; Einarson et al (2009)JOGC
14 2. Birth Defects Grigoriadis et al (2014) J Clin Psych 0.93 ( )
15 2. Cardiac Defects Huybrechts et al (2014) NEJM
16 3. Persistent Pulmonary Hypertension of the Newborn Early studies: Late pregnancy SSRI exposure associated with risk Conflicting reports, OR 2-5 Recent, statistically robust, large study (n=~4 million) All PPHN cases SSRI -- OR 1.10 ( ) Non-SSRI antidepressant -- OR 1.02 ( ) Primary PPHN SSRI -- OR 1.28 ( ) Non-SSRI antidepressant -- OR 1.14 ( ) Huybrechts et al (2015) JAMA
17 4. Preterm birth Increased risk or synergistic effects MDD alone OR 1.2 ( ) SRI alone OR 1.6 ( ) SRI + MDD OR 2.1 ( ) No difference in risk 14% rates of preterm birth in depression samples with propensity score matching, regardless of antidepressant exposure Possible protective effect (SSRI vs unmedicated depressed) Early preterm OR 0.52 ( ) Late preterm birth OR 0.84 ( ) Malm et al (2015) Am J Psych; Yonkers et al (2012); Huybrechts et al 2014
18 5. Neonatal complications Onset from birth to 4 weeks of age Self-limited - Largely gone by 2 weeks of life Most common signs Tremulousness Hypertonia Respiratory disturbance Irritability Summary risk ratio RR 3.0 ( ) NICU risk OR 1.24 ( ) Moses-Kolko et al (2005) JAMA; Malm et al (2015) Am J Psych
19 6. Lactation Relative infant dose (%) Protein binding (%) Sertraline Paroxetine Nortriptyline Citalopram Fluoxetine Bupropion Quetiapine unquantifiable Hale, Medication and Mother s Milk 2004
20 7. Neurodevelopment Duration/# MDD episodes = negative predictors Perinatal depression is associated with cognitive delays, internalizing and externalizing problems Studies comparing TCA, venlafaxine, SSRIs, and no exposure No difference in motor, mental development, IQ, language, temperament Some studies of SSRIs suggest disturbance Lower score psychomotor development More internalizing behaviors and decreased attention Slowed 6 month, but normal 19 month development Nulman et al 1997, 2002, 2012; Casper et al 2003, Pederson et al 2010, Deave et al 2008, Wisner, Santucci
21 7. Autism Spectrum Disorders Positive studies Boukhris et al 2015: HR 1.87 ( ) Rai et al 2013 : OR 3.34 ( ) Croen et al 2011: OR 2.2 ( ) Negative studies Castro et al 2016: OR 0.90 ( ) Sorenson et al 2013: OR 1.2 ( ) Hviid et al 2013: OR 1.2 ( ) Increasing methodological rigor and control for confounding magnitude and significance of the association goes down for SSRI Goes up for maternal psychiatric disorder
22 Key Points Risk is conferred by virtue of having a diagnosis Antidepressant medications are markers of that diagnosis, which have associated conditions and behaviors Low absolute risk conferred by antidepressants the increase in risk is low (<1%) Maximize maternal well-being Select treatments based upon the medicine that effectively treats your patient s depression
23 Thanks for your attention!
24 Heritability: genetic, epigenetic, environment Maternal depression Child outcomes 24
25 Checklist when reading new articles How was exposure defined? Prescriptions written medications taken Is exposure to other important factors also considered, ie: nicotine, diabetes Are diagnoses of mother and child accurate? Outcome:>1 documentation of malformation/illness code How were confounding variables accounted for? Illness subgroup analysis Propensity score matching How high is the OR or RR (>2 is preferable) and what is the increase in absolute risk? Huybrechts et al 2016
26 Barriers for prescribing to perinatal women (psychiatrist specialist perceptions) Stigma Women s fears, heightened by drug company suits Prescriber fear of legal ramifications Difficulty understanding the science Other health care provider misperceptions of risk Lack of professional guidelines for treating perinatal mental illness 26 Einarson 2016
Antidepressants. Professor Ian Jones May /WalesMentalHealth
Antidepressants Professor Ian Jones May 2017 www.ncmh.info @ncmh_wales /WalesMentalHealth 029 2074 4392 info@ncmh.info We identified 19 740 pregnancies exposed to an antidepressant at some point during
More informationPost Partum Depression. Dr. Bev Young Department of Psychiatry, Mount Sinai Hospital
Post Partum Depression Dr. Bev Young Department of Psychiatry, Mount Sinai Hospital Outline of Presentation Postpartum Mood Disorders Postpartum Blues Postpartum Depression Postpartum Psychosis Meds during
More informationDepression in Pregnancy
TREATING THE MOTHER PROTECTING THE UNBORN A MOTHERISK Educational Program The content of this program reflects the expression of a consensus on emerging clinical and scientific advances as of the date
More informationOUTCOMES OF INFANTS EXPOSED TO MULTIPLE ANTIDEPRESSANTS DURING PREGNANCY: RESULTS OF A COHORT STUDY
OUTCOMES OF INFANTS EXPOSED TO MULTIPLE ANTIDEPRESSANTS DURING PREGNANCY: RESULTS OF A COHORT STUDY A Einarson 1, J Choi 1, G Koren 1,2, TR Einarson 1,2 1 The Motherisk Program, The Hospital for Sick Children,
More informationMaternal Mental Health:
Maternal Mental Health: Impact, Identification, and Intervention Ashley Blackmon Jones, MD Associate Professor of Clinical Psychiatry Adjunct Associate Professor of Clinical Obstetrics and Gynecology April
More informationDisclosures. Objectives. Talk Overview 11/28/2016. Evidence-Based Approaches to Psychiatric Care during Pregnancy in the Age of Sensationalized Media
Evidence-Based Approaches to Psychiatric Care during Pregnancy in the Age of Sensationalized Media Disclosures Legal consultant to Astra Zeneca, Eli Lilly, Johnson and Johnson Research Support from NIMH,
More informationReport Information from ProQuest
Report Information from ProQuest 17 May 2015 07:36 17 May 2015 ProQuest Table of contents 1. Antidepressants in pregnancy... 1 17 May 2015 ii ProQuest Document 1 of 1 Antidepressants in pregnancy Author:
More informationPerinatal Mental Health: Prescribing Guidance for Trust Prescribers and GPs
Perinatal Mental Health: Prescribing Guidance for Trust Prescribers and GPs (Version 3 January 2015) Principal Author: Dr Jenny Cooke Consultant Psychiatrist, Brighton & Hove Perinatal Mental Health Service
More informationCourse and Treatment of Depression and Bipolar Illness during Pregnancy : Knowns and Unknowns
Course and Treatment of Depression and Bipolar Illness during Pregnancy : Knowns and Unknowns Lee S. Cohen, MD Director, Ammon-Pinizzotto Center for Women s Mental Health Massachusetts General Hospital
More informationDepression: Part 2. in All the Wrong Places. Treatment of Depression During Pregnancy. What Causes Depression During Pregnancy?
Guest CME: McMaster University Postpartum Title Depression: in All the Wrong Places Part 2 By Pratap Chokka, MD, FRCPC For most women, pregnancy is a time of well-being. For the vulnerable woman, however,
More informationPsychiatry for GPs Perinatal Mental Health
Psychiatry for GPs Perinatal Mental Health Dr Michael Yousif, Consultant in Psychological Medicine, OUH NHSFT Perinatal mental health for GPs Diagnosing Prescribing 2 Perinatal mental health for GPs Is
More informationPregnancy. General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition)
Pregnancy General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition) In all women of child bearing potential Always discuss the possibility of pregnancy; half of all pregnancies are unplanned
More informationSupplementary Online Content
Supplementary Online Content Viktorin A, Uher R, Kolevzon A, Reichenberg A, Levine SZ, Sandin S. Association of antidepressant medication use during pregnancy with intellectual disability in offspring.
More informationDepression PROTOCOL 3
PROTOCOL 3 Depression Kimberly Yonkers 1,2,3 1 Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA 2 Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University
More informationPerinatal Mental Health: Prescribing Guidance for Trust Prescribers and GPs
Perinatal Mental Health: Prescribing Guidance for Trust Prescribers and GPs (Version 3 January 2018) Principal Authors: Dr Jenny Cooke Consultant Psychiatrist, Brighton & Hove Perinatal Mental Health Service
More information5/24/ Maria H. Elswick, MD. Maternal Wellness Program Physician Lead
Maria H. Elswick, MD Maternal Wellness Program - Physician Lead Department of Obstetrics & Gynecology Kaiser Permanente San Diego Maria H. Elswick, MD Maternal Wellness Program Physician Lead Department
More informationPsychotropic Medications in Pregnancy. Leanne Martin MD, MSc (Medicine), FRCPC Psychiatrist Cambridge Memorial Hospital
Psychotropic Medications in Pregnancy Leanne Martin MD, MSc (Medicine), FRCPC Psychiatrist Cambridge Memorial Hospital Psychotropic Medications in Pregnancy Dr. Leanne Martin Day in Psychiatry 2018 Declaration
More informationPrenatal and Post Partum Depression is Not Just a Mood. This is Serious Stuff.
Prenatal and Post Partum Depression is Not Just a Mood. This is Serious Stuff. Deborah McMahan, MD Health Commissioner Prenatal and Infant Care Network November 28, 2016 Agenda Prevalence of mental illness
More informationTreating Peri and Postnatal Depression and Anxiety
University of North Dakota UND Scholarly Commons Physician Assistant Scholarly Project Papers Department of Physician Studies 2018 Treating Peri and Postnatal Depression and Anxiety Emily M. Stevenson
More information2 Prevalence, Clinical Course,
Depression During Pregnancy 13 2 Prevalence, Clinical Course, and Management of Depression During Pregnancy Sanjog Kalra and Adrienne Einarson Summary Depression has been identified by the World Health
More information7 th Annual ECMH Conference 2016 Alison Reminick, MD
Objectives MATERNAL DEPRESSION Director of Women s Reproductive Mental Health University California, San Diego Describe the effects of maternal depression on fetal and neonatal health Describe normal changes
More informationNEURODEVELOPMENT OF CHILDREN EXPOSED IN UTERO TO ANTIDEPRESSANT DRUGS
NEURODEVELOPMENT OF CHILDREN EXPOSED IN UTERO TO ANTIDEPRESSANT DRUGS ABSTRACT Background Many women of reproductive age have depression, necessitating therapy with either a tricyclic antidepressant drug
More informationDepression and Antidepressant Medications during Pregnancy
Depression and Antidepressant Medications during Pregnancy Teri Pearlstein, MD Director, Women s Behavioral Medicine Women s Medicine Collaborative, Miriam Hospital Professor of Psychiatry and Human Behavior
More informationAntidepressant Selection in Primary Care
Antidepressant Selection in Primary Care R E B E C C A D. L E W I S, D O O O A S U M M E R C M E B R A N S O N, M O 1 5 A U G U S T 2 0 1 5 Objectives Understand the epidemiology of depression. Recognize
More informationOne in 10 pregnant women suffers from depression;
CME EARN CATEGORY I CME CREDIT by reading this article and the article beginning on page 38 and successfully completing the posttest on page 44. Successful completion is defined as a cumulative score of
More informationDepression in Pregnancy and the Postpartum Period
Depression in Pregnancy and the Postpartum Period Sarah Gopman, MD Assistant Professor Maternal and Child Health Grand Rounds Dept. of Family and Community Medicine University of New Mexico April 4, 2012
More informationInformation for Providers on Antidepressants during Pregnancy and Breastfeeding January 2018
Antidepressants Risks in Pregnancy Safety Data: No randomized control trials. Safety data derived largely from cohort studies, registry data, and prescription monitoring registries. Older studies suggested
More informationPerinatal depression: detection and treatment
Perinatal depression: detection and treatment Maria Muzik 1, Kelsie Thelen 1 & Katherine Lisa Rosenblum 1 Practice points Perinatal depression is common, yet often unrecognized and undertreated. Failing
More informationPromoting Maternal Mental Health During and After Pregnancy
Promoting Maternal Mental Health During and After Pregnancy Leena Mittal, MD, FAPM Associate Medical Director, MCPAP for Moms Director, Reproductive Psychiatry Consultation, Brigham and Women s Hospital
More informationMother May I? Managing Mental Illness During Pregnancy: Focus on Antidepressants
Handout for the Neuroscience Education Institute (NEI) online activity: Mother May I? Managing Mental Illness During Pregnancy: Focus on Antidepressants Learning Objectives Evaluate the potential risks
More informationAdvances in Care for Pregnant and Postpartum Women With Mental Illness
F Mental Illness FMF-Toronto November 15, 2018 Advances in Care for Pregnant and Postpartum Women With Mental Illness Simone Vigod, MD, MSc, FRCPC Psychiatry, Women s College Hospital William Watson, MD,
More informationMaternal Depression: Prevalence, Implications, Diagnosis, and Current Treatment Options
Maternal Depression: Prevalence, Implications, Diagnosis, and Current Treatment Options Sarah E. (Betsy) Bledsoe-Mansori PhD, MPhil, MSW Assistant Professor Cathy Nguyen UNC School of Social Work Presented
More informationMaternal Mental Health: Risk Factors, Ramifications, and Roles. Anna Glezer MD UCSF Assistant Clinical Professor Founder, Mind Body Pregnancy
Maternal Mental Health: Risk Factors, Ramifications, and Roles Anna Glezer MD UCSF Assistant Clinical Professor Founder, Mind Body Pregnancy Disclosures None Objectives for Today Review major maternal
More informationPerinatal Mental Health Certification Blueprint (2018)
Perinatal Mental Health Certification Blueprint (2018) 1. Perinatal Mental Health Disorders (13%) 1.1 Normal perinatal emotional, cognitive, and behavior changes (e.g. blues) 1.1.1 Normal developmental/adjustment
More informationMental Health Series for Perinatal Prescribers. Perinatal Depression
Mental Health Series for Perinatal Prescribers Perinatal Depression Perinatal Depression Timing of symptoms Maternal depression is present before or during pregnancy at least 60% of the time DSM-5 and
More informationProject TEACH Addressing Tobacco Treatment for Pregnant Women Jan Blalock, Ph.D.
Project TEACH Addressing Tobacco Treatment for Pregnant Women Jan Blalock, Ph.D. Prevalence of Smoking and Cessation During Pregnancy In 2014, 14% in women with Medicaid coverage versus 3.6% of women with
More informationBRAIN STIMULATION AN ALTERNATIVE TO DRUG THERAPY IN MATERNAL DEPRESSION?
BRAIN STIMULATION AN ALTERNATIVE TO DRUG THERAPY IN MATERNAL DEPRESSION? Kira Stein, MD Medical Director West Coast Life Center Sherman Oaks, California CA Maternal Mental Health Initiative - 2013 2013
More informationARTICLE. Neonate Characteristics After Maternal Use of Antidepressants in Late Pregnancy. 1-8 HAVE BEEN PUBlished
Neonate Characteristics After Maternal Use of Antidepressants in Late Pregnancy Bengt Källén, MD, PhD ARTICLE Background: Exposure to antidepressants during the third trimester of pregnancy has been associated
More informationCommon Antidepressant Medications for Adults
(and Citalopram (Celexa) Escitalopram (Lexapro) Fluoxetine (Prozac) Fluoxetine Weekly (Prozac Weekly) 20 in AM w/ food (10 mg in elderly or those w/ panic disorder) 20 40 40 (If age >60yo, max 20) 10 10
More informationWomen s Mental Health
Women s Mental Health Linda S. Mullen, MD Director, Women s Mental Health Assistant Professor of Clinical Psychiatry in OB/GYN Columbia University & NewYork Presbyterian Hospital Departments of Psychiatry
More informationGuidance for Preconception Care of Women with Depression and Anxiety Disorders Posted July 09, 2010
Before, Between & Beyond Pregnancy The National Preconception Curriculum and Resources Guide for Clinicians Guidance for Preconception Care of Women with Depression and Anxiety Disorders Posted July 09,
More informationWomen s Mental Health
Learning Objectives Women s Mental Health Know what to do when a pt c/o PMS Gain knowledge about depression in women Be able to review risks/benefits of antidepressants during pregnancy Learn about post-partum
More informationPerinatal Mood and Anxiety Disorders Cort A. Pedersen, M.D. UNC Department of Psychiatry
Perinatal Mood and Anxiety Disorders Cort A. Pedersen, M.D. UNC Department of Psychiatry Prevalence of Perinatal Depressive and Anxiety Disorders Depression: approximately 14% within the first 2-3 months
More informationAssessment and Management of Depression Over the Female Life Cycle
Assessment and Management of Depression Over the Female Life Cycle Stephen A. Young, MD Regional Medical Officer/Psychiatry US Department of State, American Embassy, Tokyo Office of Personnel Management
More informationPSYCHIATRIC COMPLICATIONS OF PREGNANCY REX GENTRY, MD
PSYCHIATRIC COMPLICATIONS OF PREGNANCY REX GENTRY, MD OVERVIEW MISINFORMATION FROM DOCTORS BUY A DRESS, YOU LL FEEL BETTER MUCH NEEDS TO BE LEARNED YET MUCH IS NOW KNOWN COMMON YET GENERALLY UNTTREATED
More informationMOOD DISORDERS DURING PREGNANCY AND THE POSTPARTUM
MOOD DISORDERS DURING PREGNANCY AND THE POSTPARTUM Learning Objectives Implement evidence-based strategies to manage mood disorders during pregnancy Improve diagnosis and treatment of mood disorders during
More informationVirtual Mentor American Medical Association Journal of Ethics September 2013, Volume 15, Number 9:
Virtual Mentor American Medical Association Journal of Ethics September 2013, Volume 15, Number 9: 746-752. ETHICS CASE Weighing Risks and Benefits of Prescribing Antidepressants during Pregnancy Commentary
More informationCourse and Treatment of Psychiatric Disorder During Pregnancy: Lessons Learned over Two Decades
Course and Treatment of Psychiatric Disorder During Pregnancy: Lessons Learned over Two Decades Lee S. Cohen, MD Director, Ammon-Pinizzotto Center for Women s Mental Health Massachusetts General Hospital
More informationGSK Medicine: Study Number: Title: Rationale: Study Period: Objectives: Indication: Study Investigators/Centers: Data Source:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More information2015 Updates: Psychopharmacology of Pregnant & Postpartum Women
2015 Updates: Psychopharmacology of Pregnant & Postpartum Women Judy A. Greene, M.D. Director, Women s Mental Health Director, Reproductive Psychiatry Fellowship Program Clinical Assistant Professor, NYU
More informationInformation on the risks of Valproate (Epilim) use in girls (of any age), women of childbearing potential and pregnant women.
CONTAINS NEW INFORMATION GUIDE FOR HEALTHCARE PROFESSIONALS Information on the risks of Valproate (Epilim) use in girls (of any age), women of childbearing potential and pregnant women. Read this booklet
More informationOutcomes of Infants with Neonatal Abstinence Syndrome
Outcomes of Infants with Neonatal Abstinence Syndrome Caroline O. Chua, MD, FAAP Medical Director, Division of Neonatology Director, Neonatal Follow Up Clinic Nemours Children s Hospital Orlando, Florida
More informationEffects of Prenatal Illicit Drug. Use on Infant and Child
Effects of Prenatal Illicit Drug Use on Infant and Child Development Andrew Hsi, MD, MPH Larry Leeman, MD, MPH Family Medicine MCH Grand Rounds 6 July 2011 Objectives for Presentation At the end of this
More informationPregnancy and Epilepsy
Pregnancy and Epilepsy Nowhere is the problem more evident or more complicated than in pregnancy. In the United States, epilepsy affects nearly one million women of childbearing potential. Alarm bells
More informationMajor Depressive Disorder (MDD) in Children under Age 6
in Children under Age 6 Level 0 Comprehensive assessment. Refer to Principles of Practice on page 6. Level 1 Psychotherapeutic intervention (e.g., dyadic therapy) for 6 to 9 months; assessment of parent/guardian
More informationMarijuana Use During Pregnancy and Breastfeeding Findings Summary
The Colorado Department of Public Health and Environment (CDPHE) was assigned the responsibility to appoint a panel of health care professionals with expertise in cannabinoid physiology to monitor the
More informationSupplementary Online Content
Supplementary Online Content Huybrechts KF, Hernández-Díaz S, Patorno E, et al. Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiatry. Published online August 17, 2016.
More information25/04/2017. Many misconceptions, and much resistance to use Patients worry about it in pregnancy
Many misconceptions, and much resistance to use Patients worry about it in pregnancy Lexy Regush Opioid Substitution Conference April 30 2017 Uninformed healthcare providers (HCPs) see methadone as a marker
More informationCurrents: Dr. Cohen, are benzodiazepines teratogenic?
Update on Reproductive Safety of Psychotropic Medications Part II of an Interview with Lee S. Cohen, M.D. (Dr. Cohen is Director, Perinatal and Reproductive Psychiatry Clinical Research Program, and Associate
More informationScreening for. perinatal depression. ACOG CO No. 757, Nov 2018 Kristen Giefer, PGY-2
Screening for perinatal depression ACOG CO No. 757, Nov 2018 Kristen Giefer, PGY-2 Introduction Prevalence of perinatal depression is a significant cost to individuals, children, families and the community
More informationNEONATAL ABSTINENCE SYNDROME (NAS) AKA NEWBORN DRUG WITHDRAWAL:THE NEWARK EXPERIENCE
NEONATAL ABSTINENCE SYNDROME (NAS) AKA NEWBORN DRUG WITHDRAWAL:THE NEWARK EXPERIENCE Salma Ali MD, Debra Brendel RN, BSN, MSN and Ona Fofah MD Division of Neonatology and Newborn Medicine Department of
More informationWhat is Statistics? Ronghui (Lily) Xu (UCSD) An Introduction to Statistics 1 / 23
What is Statistics? Some definitions of Statistics: The science of Statistics is essentially a branch of Applied Mathematics, and maybe regarded as mathematics applied to observational data. Fisher The
More informationAN UPDATE ON THE USE OF ANTIDEPRESSANTS IN PREGNANT AND BREASTFEEDING WOMEN FOR MIDWIVES
AN UPDATE ON THE USE OF ANTIDEPRESSANTS IN PREGNANT AND BREASTFEEDING WOMEN FOR MIDWIVES Adria Goodness, CNM, PMHNP Portland, Oregon 1 DISCLOSURES I HAVE NO FINANCIAL RELATIONSHIPS TO DISCLOSE. DARN. 2
More informationPharmacologic Considerations in the Pregnant Patient (For the PCP)
Pharmacologic Considerations in the Pregnant Patient (For the PCP) Aspirin Use in Pregnancies At Risk Contemporary Treatment of the A2 Diabetic Statin Exposure in Early Pregnancy Continuation of SSRI Rx
More informationMarijuana During Pregnancy: An Overview
Marijuana During Pregnancy: An Overview Marijuana: Epidemiology Marijuana is the most commonly used illicit drug and, after alcohol and tobacco, the most commonly used drug during pregnancy (1) 48-60%
More informationWomen are at the highest risk of having a major depressive disorder (MDD)
FOLLOW-UP OF CHILDREN OF DEPRESSED MOTHERS EXPOSED OR NOT EXPOSED TO ANTIDEPRESSANT DRUGS DURING PREGNANCY REGINA C. CASPER, MD, BARRY E. FLEISHER, MD, JULIE C. LEE-ANCAJAS, PHD, ALLYSON GILLES, BA, ERIKA
More informationMaternal and Fetal Outcomes After Lamotrigine Use in Pregnancy: A Retrospective Analysis from an Urban Maternal Mental Health Centre in New Zealand
General Psychiatry Key Words: lamotrigine, mood stabilisers, bipolar disorder, fetal and maternal outcomes Maternal and Fetal Outcomes After Lamotrigine Use in Pregnancy: A Retrospective Analysis from
More informationMARIJUANA USE AMONG PREGNANT AND POSTPARTUM WOMEN
MARIJUANA USE AMONG PREGNANT AND POSTPARTUM WOMEN Symposium on Marijuana Research in Washington May 18, 2018 THERESE GRANT, PH.D. PROFESSOR, DEPARTMENT OF PSYCHIATRY & BEHAVIORAL SCIENCES UNIVERSITY OF
More informationSupplementary Online Content
Supplementary Online Content Renoux C, Vahey S, Dell Aniello S, Boivin J-F. Association of selective serotonin reuptake inhibitors with the risk for spontaneous intracranial hemorrhage. JAMA Neurol. Published
More informationIt Is Time for Routine Screening for Perinatal Mood and Anxiety Disorders in Obstetrics and Gynecology Settings
CME Volume 72, Number 9 OBSTETRICAL AND GYNECOLOGICAL SURVEY Copyright 2017 Wolters Kluwer Health, Inc. All rights reserved. REVIEWARTICLE 00 CHIEF EDITOR S NOTE: This article is part of a series of continuing
More informationCNS SPECTRUMS. CME Review Article. Between a Rock-a-bye and a Hard Place: Mood Disorders During the Peripartum Period
CNS SPECTRUMS CME Review Article Between a Rock-a-bye and a Hard Place: Mood Disorders During the Peripartum Period This activity is provided by the Neuroscience Education Institute. Additionally provided
More informationThe New GDM Screening Guidelines. Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program
The New GDM Screening Guidelines Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program Disclosures Current participant (RCH site) for MiTy study Metformin in women
More informationReviews/Evaluations. Use of Selective Serotonin Reuptake Inhibitors in Pediatric Patients. Pharmacotherapeutic Options
Reviews/Evaluations Use of Selective Serotonin Reuptake Inhibitors in Pediatric Patients Childhood major depressive disorder (MDD) has become recognized as a serious and common illness affecting between
More informationCENTER OF EXCELLENCE MATERNAL AND CHILD MENTAL HEALTH (MCMH)
CENTER OF EXCELLENCE MATERNAL AND CHILD MENTAL HEALTH (MCMH) The infant and young child should experience a warm, intimate, and continuous relationship with his mother in which both find satisfaction and
More information5 COMMON QUESTIONS WHEN TREATING DEPRESSION
5 COMMON QUESTIONS WHEN TREATING DEPRESSION Do Antidepressants Increase the Possibility of Suicide? Will I Accidentally Induce Mania if I Prescribe an SSRI? Are Depression Medications Safe and Effective
More informationAvailable online at General Hospital Psychiatry xx (2009) xxx xxx
Available online at www.sciencedirect.com General Hospital Psychiatry xx (2009) xxx xxx The management of depression during pregnancy: a report from the American Psychiatric Association and the American
More informationSupplementary Online Content
Supplementary Online Content Sandin S, Nygren K-G, Iliadou A, Hultman C, Reichenberg. Autism and Mental Retardation Among Offspring Born After In Vitro Fertilization. JAMA. doi:10.1001/jama.2013.7222.
More informationMental Health and Women s Health
Disclosure information I have nothing to disclose. Mental Health and Women s Health Ellen Haller, M.D. Professor of Clinical UCSF Department of Learning Objectives Know what to do when a pt c/o PMS/PMDD
More informationUse of Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Congenital Cardiac Malformations
Pacific University CommonKnowledge School of Physician Assistant Studies Theses, Dissertations and Capstone Projects Summer 8-13-2016 Use of Selective Serotonin Reuptake Inhibitors During Pregnancy and
More informationObsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care
Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care CLINICAL ASSESSMENT AND DIAGNOSIS (ADULTS) Obsessive-Compulsive Disorder (OCD) is categorized by recurrent obsessions,
More informationThe burden of mental disorders, such as depression and anxiety, fall disproportionately on women of childbearing and childrearing age.
The burden of mental disorders, such as depression and anxiety, fall disproportionately on women of childbearing and childrearing age. Psychiatric Clinics of North America, 2007 Rates of severe mental
More informationEVALUATING PERINATAL MOOD DISORDERS. For Healthcare Providers
EVALUATING PERINATAL MOOD DISORDERS For Healthcare Providers Nothing to disclose Educational Objectives Understand Perinatal Mood Disorders Describe appropriate screening procedures for perinatal mood
More informationMAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids
MAT IN PREGNANCY R. COREY WALLER MD, MS PRINCIPAL, HEALTH MANAGEMENT ASSOCIATES FACULTY, INSTITUTE FOR HEALTHCARE INNOVATION (IHI) CHAIR, LEGISLATIVE ADVOCACY COMMITTEE, ASAM KAYLA LIFE STAGE 1: ADOLESCENCE
More informationAnnex III. Amendments to relevant sections of the summary of product characteristics and package leaflets
Annex III Amendments to relevant sections of the summary of product characteristics and package leaflets Note: These amendments to the relevant sections of the Summary of Product Characteristics and package
More informationPerinatal Depression Treatment and prevention. Dr. Maldonado
Perinatal Depression Treatment and prevention Dr. Maldonado What is postnatal depression? Is it truly a unique disorder? Are there specific features? Is there a higher frequency in the puerperium? Are
More information%, # Southern Medical Association July / 01/ /7 23 #, 2 3
Southern Medical Association July 2011 Robert A. Bashford, M.D., Professor Associate Dean for Admissions University of North Carolina Professor of Psychiatry and OB-GYN!" #! $ %&'(%&) $ * &+ %&, ' ) #
More informationMajor Depressive Disorder (MDD) in Children under Age 6
in Children under Age 6 Level 0 Comprehensive assessment. Refer to Principles of Practice on page 5. Level 1 Psychotherapeutic intervention (e.g., dyadic therapy) for 6 to 9 months; assessment of parent/guardian
More informationThe Science and Practice of Perinatal Tobacco Use Cessation
1 The Science and Practice of Perinatal Tobacco Use Cessation Erin McClain, MA, MPH Catherine Rohweder, DrPH Cathy Melvin, PhD, MPH erin_mcclain@unc.edu Prevention of Tobacco Use and Secondhand Smoke Exposure
More informationEmergent Issues Affecting Early Intervention/ Early Childhood. Workforce Development for Inclusion in Early Childhood November 4, 2017 Washington, DC
Emergent Issues Affecting Early Intervention/ Early Childhood Workforce Development for Inclusion in Early Childhood November 4, 2017 Washington, DC Conversation Points Changing Demographics Emergent Trends
More informationDepression & Anxiety in Adolescents
Depression & Anxiety in Adolescents Objectives 1) Review diagnosis of anxiety and depression in adolescents 2) Provide overview of evidence-based treatment options 3) Increase provider comfort level with
More informationMedication management of anxiety & depression. Dr Katie Simpson GP Mental health lead East Berks CCG
Medication management of anxiety & depression Dr Katie impson GP Mental health lead East Berks CCG NICE guidelines for Anxiety tepped Care RIs and NRIs in Anxiety disorders RI ertraline Citalopram Fluoxetine
More informationPostpartum Depression (PPD) Women s Health Connecticut Practice Guideline
Postpartum Depression (PPD) Women s Health Connecticut Practice Guideline Definitions Baby Blues Very common, affects about 70-85% of new mothers. Also know as postpartum blues, usually start within three
More informationReducing the Anxiety of Pediatric Anxiety Part 2: Treatment
Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Lisa Lloyd Giles, MD Medical Director, Behavioral Consultation, Crisis, and Community Services Primary Children s Hospital Associate Professor,
More informationPostpartum Depression: It s not just the blues. D. Yvette LaCoursiere University of Utah Department of Obstetrics and Gynecology
Postpartum Depression: It s not just the blues D. Yvette LaCoursiere University of Utah Department of Obstetrics and Gynecology Overview Postpartum Blues Postpartum Psychosis Postpartum Depression Etiology
More informationRelationships Relationships
PRENATAL OPIATE EXPOSURE IMPACT ON EARLY CHILDHOOD LEARNING AND BEHAVIOR Ira J. Chasnoff, MD NTI Upstream www.ntiupstream.com Children grow and develop in the context of Attachment: Basic Concept Attachment:
More informationAutism spectrum disorder in under 19s: recognition, referral and diagnosis
1 National Institute for Health and Care Excellence Final Autism spectrum disorder in under 19s: recognition, referral and diagnosis [A] Evidence review for factors and neurodevelopmental disorders that
More informationThe Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome
Neonatal Nursing Education Brief: The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome https://www.seattlechildrens.org/healthcareprofessionals/education/continuing-medical-nursing-education/neonatalnursing-education-briefs/
More informationA case based discussion of depression across the reproductive life cycle of an EFM.
A case based discussion of depression across the reproductive life cycle of an EFM. VALERIE K DAVIS, MD RMO/P, MANAMA JANUARY, 2014 Identifying data: 36 year old married G4P4Absp1 mostly stay-at-home mother
More informationMental Health for Women s Health
Mental Health for Women s Health Ellen Haller, M.D. WomenCare Mental Health Program Depression Center @ UCSF UCSF Department of Learning Objectives Know what to do when a pt c/o PMS Gain knowledge about
More information